Event review Compamed 2019 breaks record

This year’s Compamed trade fair was bigger and better than all its previous editions. A whooping 800 exhibitors from 41 countries participated at this trade fair which showcased many revolutionary innovations for the medical technology industry.

Compamed is one of the leading events for the medical technology industry across the globe. Held concurrently with Medica, the world’s biggest medical trade fair, Compamed was hosted for four days beginning from November 18, 2019 in Germany. The Medica show received participation of around 5,500 exhibitors while Compamed witnessed nearly 800 exhibitors from 41 countries. The organisers of the show Messe Duesseldorf have revealed that this is a new record in participation.

Overall the trade fairs welcomed 121,000 trade visitors out of which two-thirds came from abroad, representing some 170 countries. The exhibitions also witnessed the presence of many international delegations from different regions such as Asia, North Africa and South America. The high profile Asian delegation included Thailand’s Deputy Prime Minister and Trade Minister Jurin Laksanawisit.

Event review

EMO Hannover 2019: bold, smart and innovative

Innovations highlighted at Compamed 2019

The Compamed exhibition caters to the increasing demand of powerful components and digitalised solutions for mobile devices for diagnostics, therapy and laboratory equipment.

Micro technologies: One of the highlights at the event was the stunning display of miniaturised components or micro technologies for the medical technology industry. Around 55 exhibitors showcased these specialised innovations at IVAM’s joint exhibition stand.

Cell culture revolution: Some of the other noteworthy innovations at the expo included Micronit’s cell culture revolution. Based on the ‘Organ on a chip’ concept, human cell biology and microfluidics are merged together on lab-on-a-chip architecture. Organ-on-a-chip devices comprises a microfluidic platform which the user manipulates to tailor-make a highly biomimetic system in an artificial environment. The cell culture chips simulate the physiological reactions of organs. Experts state that these types of applications are the fastest-growing research areas in the life science and pharmaceutical industries.

The relevant devices from Micronit have already been used in many research laboratories all over the world and have proven that they are perfect for creating artificial models in the field, including colon and kidney models. “The systems for these are often constructed using different materials such as glass, silicon and polymers; hybrids such as these are part of our core business skill set”, stated Remy Wiertz, Key Account Manager at Micronit.

Factories of the future

umati is this year’s most outstanding innovation

Isolating and detecting cells: In addition to this, there were many other innovations exhibited at the event such as the micro dispensing system by the Fraunhofer Institute for Microengineering and Microsystems (IMM). The system has been developed to automate methods for isolating and detecting cells for diagnosing cancer. The system can detect a few cells in a mass of cells completely automatically and pick them out, placing each individual cell in a separate well on a microtiter plate to make them available for further analysis. There were many other unique solutions that were exhibited at the show.

Specialist forums for industry players

Apart from state-of-the-art innovations, the Compamed event also hosted two specialist forums which offered an insight into the industrial trends of the medical technology and also focused on all aspects of the development, manufacture and approval of medical products. This covered diverse segments such as electronics manufacturing, machining of plastics and metal, regulations, supplier’s role as an important pace setter for medical advancement, and many more associated topics.

The next edition of Compamed is scheduled to be held from November 16 – 19, 2020.

For more news visit our facebook page or twitter.

(ID:46290832)